Group will help Center to Reduce Cancer Health Disparities determine NCI’s diversity training, biomedical workforce development, and community outreach and engagement initiatives.
Researchers at City of Hope were awarded $32.3 million from the CIRM to support three novel Phase 1 clinical trials evaluating innovative cell and gene therapy treatments for patients with HIV, acute myeloid leukemia and severe aplastic anemia.
/PRNewswire/ Researchers at City of Hope, one of the largest cancer research and treatment organizations in the United States and a leading research center.